Sign in

Dr Jonathan OLIVIER

@jo-uro.bsky.social
17 followers 30 following 2 posts

MD PhD MCU-PH Urologist Robot-Laser surgery &UroOnco @CHU_Lille. Coordinateur relations internationales @medecine_Ulille. Member @EAU_YAUProstate

PostsRepliesMedia
Dr Jonathan OLIVIER @jo-uro.bsky.social · 27/08/2025
Thrilled to share our new @BJUIjournal study! 📊 Quantifying Gleason pattern 4 via MRI & targeted biopsy predicts prostate cancer metastasis better than standard Gleason grading & risk scores. Precision matters in risk stratification. 🔗 doi.org/10.1111/bju.... @vickersbiostats.bsky.social
doi.org
Quantification of prostate cancer Gleason pattern 4 to predict oncological outcome
Objectives To determine if quantifying Gleason pattern 4 (GP4) is superior to Grade Group (GG) in predicting any and distant metastatic recurrence after radical prostatectomy (RP) for prostate cance...
121
Dr Jonathan OLIVIER @jo-uro.bsky.social · 19/01/2025
Happy to share our new meta-analysis that highlights a critical finding: 16% of mCRPC cases treated with ARPIs transition to t-NEPC. Routine biopsies could improve detection of this progression. @chulille.bsky.social @eururoloncol.bsky.social euoncology.europeanurology.com/article/S258...
euoncology.europeanurology.com
Emergence of Neuroendocrine Tumors in Patients Treated with Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer: A Systematic Review and Meta-analysis
Androgen receptor pathway inhibitor treatment for metastatic castration-resistant prostate cancer (PC) can lead to the development of neuroendocrine PC (t-NEPC) in approximately 16% of cases. This agg...
031